|
Market Closed -
Other stock markets
|
After hours 02:58:21 | |||
| 59.85 USD | +3.74% |
|
59.76 | -0.14% |
| 07-15 | RxSight Names Aziz Mottiwala as CEO | MT |
| 07-14 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.74% | +2.94% | -4.32% | -10.99% | -26.91% | +44.57% | +218.35% | +135.72% | - | 2.48B | |
| -0.33% | +1.83% | +11.31% | -9.84% | -12.33% | +23.03% | -6.22% | +16.02% | +81.03% | 69.07B | |
| +0.67% | +0.93% | -5.19% | -9.32% | +0.29% | +37.53% | +198.53% | +168.76% | +251.91% | 51.77B | |
| +0.94% | +39.60% | +39.60% | +39.60% | +39.60% | +39.60% | +39.60% | +39.60% | - | 43.63B | |
| +1.12% | +0.35% | +15.48% | -10.07% | -28.57% | -50.35% | -52.35% | -55.60% | +8.88% | 40.89B | |
| -1.40% | +3.43% | +3.68% | +16.15% | +17.05% | +60.07% | -26.01% | -36.54% | -20.86% | 30.84B | |
| -2.11% | -9.45% | +0.03% | +15.08% | +109.63% | +91.99% | -49.58% | -78.42% | - | 25.06B | |
| +0.51% | +0.46% | +18.45% | +19.86% | +18.71% | +70.08% | +91.96% | +49.69% | +39.87% | 23.3B | |
| -5.57% | -0.84% | +18.84% | -2.79% | +16.66% | -0.17% | +174.11% | +1.31% | - | 20.92B | |
| -0.86% | -1.99% | +4.86% | +9.69% | +38.76% | +68.42% | +124.39% | +189.80% | +305.09% | 16.71B | |
| +1.34% | -5.25% | +20.76% | +6.03% | +6.39% | +74.11% | +154.00% | +37.51% | - | 15.74B | |
| -2.97% | -1.63% | -8.79% | +21.70% | +25.93% | +104.92% | +213.86% | +324.20% | +2,757.14% | 12.2B | |
| -0.68% | +0.79% | +8.31% | +9.06% | +0.27% | +2.09% | -31.24% | -24.42% | -35.28% | 11.6B | |
| +3.82% | -2.99% | +3.86% | +29.41% | +43.94% | +136.34% | +177.49% | +458.22% | - | 10.08B | |
| -4.16% | -14.66% | -25.87% | -24.45% | -38.49% | -43.40% | +572.75% | +274.49% | +4,135.74% | 10B | |
| -13.72% | -16.53% | +13.64% | -25.49% | +7.27% | +4.83% | +268.95% | +233.86% | - | 6.76B | |
| -0.59% | +1.95% | +0.82% | -5.89% | -15.16% | -25.77% | -29.35% | -56.14% | -54.04% | 6.29B | |
| -7.39% | -3.31% | +18.84% | -1.35% | -5.58% | +9.60% | +56.49% | -26.13% | - | 6.1B | |
| -9.83% | -10.63% | +0.56% | -36.06% | -33.21% | -47.22% | +122.45% | +89.78% | +101.62% | 5.71B | |
| +2.87% | +3.55% | +13.25% | +56.91% | +195.87% | +161.79% | +288.29% | -16.29% | - | 5.68B | |
| Average | -1.73% | -1.60% | +7.41% | +4.36% | +18.01% | +38.10% | +125.32% | +86.27% | +688.28% | 20.74B | |
| Weighted average by Cap. | -0.76% | -0.85% | +10.29% | +4.78% | +13.70% | +34.31% | +77.85% | +57.88% | +356.34% |
- Stock Market
- Stocks
- TARS Stock
- Sector Tarsus Pharmaceuticals, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
